Escalon Medical Corp (ESMC) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
435 DEVON PARK ROAD WAYNE, PA 19087 |
| State of Incorp. | PA |
| Fiscal Year End | June 30 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 MRQ | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 209 | 890 | 594 | 1,651 | 826 | 410 | |||
| Cash and cash equivalent | 209 | 890 | 594 | 1,651 | 826 | 410 | |||
| Restricted cash and investments | 256 | 256 | 256 | 256 | 255 | 253 | |||
| Receivables | 2,124 | 1,654 | 1,542 | 1,082 | 1,313 | 1,496 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,613 | 1,588 | 1,604 | 1,417 | 1,785 | 1,879 | |||
| Inventory | 1,613 | 1,588 | 1,604 | 1,417 | 1,785 | 1,879 | |||
| Other current assets | 194 | 250 | 190 | 187 | 154 | 275 | |||
| Other undisclosed current assets | |||||||||
| Total current assets: | 4,397 | 4,637 | 4,186 | 4,593 | 4,333 | 4,313 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 200 | 504 | 788 | 844 | 1,107 | ✕ | |||
| Property, plant and equipment | 49 | 34 | 53 | 81 | 97 | 68 | |||
| Intangible assets, net (including goodwill) | 49 | 70 | 83 | 102 | 122 | 747 | |||
| Intangible assets, net (excluding goodwill) | 49 | 70 | 83 | 102 | 122 | 747 | |||
| Deposits noncurrent assets | 63 | 63 | 63 | 63 | 63 | ||||
| Total noncurrent assets: | 361 | 670 | 986 | 1,090 | 1,389 | 815 | |||
| TOTAL ASSETS: | 4,758 | 5,308 | 5,172 | 5,683 | 5,723 | 5,127 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,946 | 1,857 | 2,360 | 1,798 | 1,442 | 1,537 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 112 | |||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 446 | 102 | ||||
| Accounts payable | 1,357 | 1,206 | 1,012 | 1,102 | 761 | 667 | |||
| Accrued liabilities | 588 | 652 | 902 | 696 | 681 | 657 | |||
| Deferred revenue | 280 | 426 | 332 | 364 | 516 | ✕ | |||
| Debt | 37 | 40 | 208 | 708 | 426 | 205 | |||
| Disposal group, including discontinued operation | 86 | 87 | 130 | 136 | 90 | 91 | |||
| Other liabilities | |||||||||
| Due to related parties | ✕ | ✕ | 112 | 112 | 112 | ||||
| Other undisclosed current liabilities | 320 | 442 | (141) | 279 | 279 | 427 | |||
| Total current liabilities: | 2,669 | 2,853 | 3,002 | 3,397 | 2,865 | 2,260 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 129 | 160 | 543 | 638 | 908 | 15 | |||
| Long-term debt, excluding current maturities | 129 | 160 | 4 | 8 | 12 | 15 | |||
| Liabilities, other than long-term debt, including: | 8 | 214 | 41 | 9 | 690 | ||||
| Liability, pension and other postretirement and postemployment benefits | 690 | ||||||||
| Other liabilities | 41 | ||||||||
| Operating lease, liability | 8 | 214 | 539 | 630 | 897 | ✕ | |||
| Other undisclosed liabilities, other than long-term debt | 9 | ||||||||
| Other undisclosed noncurrent liabilities | 143 | 146 | (389) | 147 | 429 | ||||
| Total noncurrent liabilities: | 279 | 520 | 692 | 826 | 1,346 | 705 | |||
| Total liabilities: | 2,948 | 3,373 | 3,694 | 4,223 | 4,211 | 2,965 | |||
| Equity | |||||||||
| Equity, attributable to parent | 1,810 | 1,935 | 1,478 | 1,460 | 1,512 | 2,162 | |||
| Preferred stock | 645 | 645 | 645 | 645 | 645 | 645 | |||
| Common stock | 7 | 7 | 7 | 7 | 7 | 7 | |||
| Additional paid in capital | 69,702 | 69,702 | 69,702 | 69,702 | 69,702 | 69,702 | |||
| Accumulated deficit | (68,545) | (68,420) | (68,876) | (68,895) | (68,842) | (68,192) | |||
| Total equity: | 1,810 | 1,935 | 1,478 | 1,460 | 1,512 | 2,162 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,758 | 5,308 | 5,172 | 5,683 | 5,723 | 5,127 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11,982 | 12,180 | 10,703 | 10,472 | 9,400 | 9,627 | ||
| Cost of revenue | (6,852) | (6,699) | (6,096) | (6,044) | (12) | (5,003) | ||
| Cost of product and service sold | (6,835) | (6,699) | (6,096) | (6,044) | (4,997) | |||
| Provision for loan, lease, and other losses | (12) | |||||||
| Gross profit: | 5,130 | 5,481 | 4,607 | 4,427 | 9,388 | 4,624 | ||
| Operating expenses | (5,234) | (5,003) | (5,077) | (4,461) | (4,877) | |||
| Other undisclosed operating loss | (10,788) | |||||||
| Operating income (loss): | (104) | 479 | (470) | (34) | (1,400) | (253) | ||
| Nonoperating income (expense) | (21) | (22) | 488 | (18) | 749 | 3 | ||
| Investment income, nonoperating | 0 | 0 | 1 | 4 | 9 | |||
| Other nonoperating income (expense) | 506 | 3 | 759 | 11 | ||||
| Interest and debt expense | (21) | (22) | (18) | (22) | (14) | (17) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Income (loss) from continuing operations before income taxes: | (146) | 435 | (0) | (74) | (664) | (267) | ||
| Income tax expense (benefit) | 66 | 10 | (57) | |||||
| Income (loss) from continuing operations: | (146) | 435 | (0) | (8) | (653) | (324) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (0) | (8) | (653) | (324) | |
| Net income (loss): | (146) | 435 | (0) | (8) | (653) | (324) | ||
| Other undisclosed net income (loss) attributable to parent | 21 | 22 | 18 | (44) | 3 | 74 | ||
| Net income (loss) attributable to parent: | (125) | 457 | 18 | (52) | (650) | (250) | ||
| Preferred stock dividends and other adjustments | (52) | (52) | (52) | (51) | (52) | (52) | ||
| Undistributed earnings (loss) allocated to participating securities, basic | (184) | |||||||
| Net income (loss) available to common stockholders, basic: | (177) | 222 | (34) | (103) | (702) | (302) | ||
| Convertible preferred dividends | 52 | 52 | 52 | |||||
| Other undisclosed net income (loss) available to common stockholders, diluted | (52) | 132 | 52 | 52 | ||||
| Net income (loss) available to common stockholders, diluted: | (177) | 405 | 18 | (103) | (650) | (250) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (146) | 435 | (0) | (8) | (653) | (324) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (146) | 435 | (0) | (8) | (653) | (324) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.